Skip to main content

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Recruiting · Phase 2 · NCT06846320

Conditions: Generalized Anxiety Disorder (GAD)

At a glance

Research payments reported, 2025
$2.0M
U.S. investigators named
53
Sites paid
74
Planned or actual enrollment
315

About the trial

Sponsor
AbbVie
Tested
ABBV-932 (drug), Placebo for ABBV-932 (drug), Antidepressant Therapy (ADT) (drug)
Dates
Started 2025-04-29; completion 2026-11
Results posted
Not yet

Generalized anxiety disorder (GAD) is usually treated with antidepressant therapy (ADT); however, sometimes ADTs alone are not enough to adequately treat GAD. The purpose of this study is to assess how safe and effective ABBV-932 is when added to the antidepressant therapies in adult participants with GAD who have had an inadequate response ADTs. ABBV-932 is an investigational drug being developed for the adjunctive treatment of GAD. Participants will be randomly assigned to receive ABBV-932 or Placebo in addition to their currently prescribed ADTs. There is 1 in 3 chance of participants assigned to Placebo. Approximately 315 adult participants with GAD and inadequate response to ADTs wil…

From ClinicalTrials.gov, last updated 2026-06-17. Full record, eligibility and contacts (opens in a new tab)

Industry funding

AbbVie Inc. reported $2.0M in research payments for this study in 2025 (388 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Allied Biomedical Research $193,606
  • Viking Pharmaceutical Trials Inc $141,732
  • Northwest Clinical Research Ctr $119,395
  • New Hope Clinical Research Inc $119,300
  • University of Cincinnati $110,716
  • Lehigh Center for Clinical Research $105,550
  • Bio Behavioral Health $93,605
  • Atlas Intermediate LLC $58,216
  • Sooner Clinical Research Inc $53,897
  • Im Super Holdings LLC $49,325
  • Oasis Clinical Research LLC $47,577
  • Sunwise Clinical Research LLC $41,686
  • Psychiatric Care and Research $41,476
  • Clinical Neuroscience Solutions in $41,430
  • Sun Valley Research Center Inc $40,622
  • University of Alabama Hospital, AL $36,902
  • Global Medical Institutes $35,778
  • Coastal Carolina Research Cntr LLC $35,153
  • St Charles Psychiatric Associates $32,776
  • The Ohio State University $31,379
  • Apg Research LLC $29,288
  • Cbh Health LLC $28,164
  • Axiom Research LLC $25,495
  • The University of Chicago $25,042
  • Excell Research Inc $24,717
  • Sandhill Research LLC $24,018
  • K2 Medical Research Maitland LLC $23,816
  • Cenexel Iresearch LLC $23,062
  • Arch Clinical Trials LLC $22,978
  • Eastside Therapeutic Resource Inc $22,525
  • Global Medical Institutes LLC $21,767
  • $21,516
  • Barbara Diaz Hernandez $19,617
  • Haidar Almhana Nieding LLC $19,462
  • Collective Medical Research LLC $19,400
  • Relaro Medical Trials LLC $19,023
  • Erg Clinical Research California PC $18,668
  • Perceptive Pharma Research LLC $17,791
  • Noble Clinical Research LLC $16,292
  • Elixia Ma LLC $16,268
  • Mrc Geriatric Services Inc $14,887
  • Instituto De Neurologia $14,500
  • Psychiatric Consultants PC $13,846
  • Inspira Mental Health Management $12,500
  • Psych Atlanta PC $11,027
  • Accellacare US Inc $11,027
  • Ima Evaluations LLC $4,384
  • Viking Clinical Research $3,759
  • Montano Wellness LLC $3,713
  • Elligo Health Research Inc $3,446
  • Grayline Research Center $3,446
  • Coastal Carolina Research Center $3,446
  • Atlas Intermediate $3,446
  • Saint Charles Psychiatric Associates and Midwest Research Group $3,446
  • Northwest Clinical Research Center $3,446
  • Psychiatric Care and Research Center $3,446
  • Inspira Caguas $3,446
  • Sunwise Clinical Research $3,446
  • Clinical Neuroscience Solutions Inc $3,446
  • Cenexel Iresearch Atlanta $3,132
  • Collective Medical Research $3,132
  • Elixia $3,132
  • Allied Biomedical Research Institute $3,132
  • Haidar Almhana and Nieding LLC $3,132
  • Northwest Behavioral Research Center $3,132
  • Eastside Therapeutic Resources $2,819
  • Ohio State University $2,819
  • Asclepes Research Centers $2,819
  • Oasis Clinical Research $2,506
  • Fraga Berrios Ivone Office $2,192
  • Relaro Medical Trials $1,565
  • Family Psychiatry of the Woodlands $1,252
  • Futuresearch Trials $939
  • Ucm Emergency Department Outpatient Pharmacy $939
  • Integrative Clinical Trials $625

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.